Yen Ting Chen - Publications

Affiliations: 
Scripps Research Institute Florida 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Kennedy NM, Schmid CL, Ross NC, Lovell KM, Yue Z, Chen YT, Cameron MD, Bohn LM, Bannister TD. Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias. Journal of Medicinal Chemistry. PMID 30199635 DOI: 10.1021/Acs.Jmedchem.8B01136  0.566
2014 Li J, Huang J, Jeong JH, Park SJ, Wei R, Peng J, Luo Z, Chen YT, Feng Y, Luo JL. Selective TBK1/IKKi dual inhibitors with anticancer potency. International Journal of Cancer. Journal International Du Cancer. 134: 1972-80. PMID 24150799 DOI: 10.1002/Ijc.28507  0.411
2013 Andero R, Brothers SP, Jovanovic T, Chen YT, Salah-Uddin H, Cameron M, Bannister TD, Almli L, Stevens JS, Bradley B, Binder EB, Wahlestedt C, Ressler KJ. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Science Translational Medicine. 5: 188ra73. PMID 23740899 DOI: 10.1126/Scitranslmed.3005656  0.554
2013 Chowdhury S, Chen YT, Fang X, Grant W, Pocas J, Cameron MD, Ruiz C, Lin L, Park H, Schröter T, Bannister TD, Lograsso PV, Feng Y. Amino acid derived quinazolines as Rock/PKA inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 1592-9. PMID 23416002 DOI: 10.1016/J.Bmcl.2013.01.109  0.648
2013 Chen YT, Brinen LS, Kerr ID, Hansell E, Doyle PS, McKerrow JH, Roush WR. Structure of WRR-483 bound to cruzain Plos Neglected Tropical Diseases. DOI: 10.1371/Journal.Pntd.0000825.G003  0.381
2011 Zhou Y, Agudelo J, Lu K, Goetz DH, Hansell E, Chen YT, Roush WR, McKerrow J, Craik CS, Amberg SM, Simmons G. Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay. Antiviral Research. 92: 187-94. PMID 21820471 DOI: 10.1016/J.Antiviral.2011.07.016  0.484
2011 Fang X, Chen YT, Sessions EH, Chowdhury S, Vojkovsky T, Yin Y, Pocas JR, Grant W, Schröter T, Lin L, Ruiz C, Cameron MD, LoGrasso P, Bannister TD, Feng Y. Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 1844-8. PMID 21349713 DOI: 10.1016/J.Bmcl.2011.01.039  0.67
2011 Chen YT, Vojkovsky T, Fang X, Pocas JR, Grant W, Handy AMW, Schröter T, Lograsso P, Bannister TD, Feng Y. Asymmetric synthesis of potent chroman-based Rho kinase (ROCK-II) inhibitors Medchemcomm. 2: 73-75. DOI: 10.1039/C0Md00194E  0.67
2010 Yin Y, Cameron MD, Lin L, Khan S, Schröter T, Grant W, Pocas J, Chen YT, Schürer S, Pachori A, LoGrasso P, Feng Y. Discovery of Potent and Selective Urea-Based ROCK Inhibitors and Their Effects on Intraocular Pressure in Rats. Acs Medicinal Chemistry Letters. 1: 175-9. PMID 24900192 DOI: 10.1021/Ml1000382  0.483
2010 Chen YT, Brinen LS, Kerr ID, Hansell E, Doyle PS, McKerrow JH, Roush WR. In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi. Plos Neglected Tropical Diseases. 4. PMID 20856868 DOI: 10.1371/Journal.Pntd.0000825  0.507
2010 Fang X, Yin Y, Chen YT, Yao L, Wang B, Cameron MD, Lin L, Khan S, Ruiz C, Schröter T, Grant W, Weiser A, Pocas J, Pachori A, Schürer S, et al. Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors. Journal of Medicinal Chemistry. 53: 5727-37. PMID 20684608 DOI: 10.1021/Jm100579R  0.499
2010 Sessions EH, Smolinski M, Wang B, Frackowiak B, Chowdhury S, Yin Y, Chen YT, Ruiz C, Lin L, Pocas J, Schröter T, Cameron MD, LoGrasso P, Feng Y, Bannister TD. The development of benzimidazoles as selective rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 1939-43. PMID 20167489 DOI: 10.1016/J.Bmcl.2010.01.124  0.667
2008 Chen YT, Bannister TD, Weiser A, Griffin E, Lin L, Ruiz C, Cameron MD, Schürer S, Duckett D, Schröter T, LoGrasso P, Feng Y. Chroman-3-amides as potent Rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 6406-9. PMID 18990570 DOI: 10.1016/J.Bmcl.2008.10.080  0.674
2008 Chen YT, Lira R, Hansell E, McKerrow JH, Roush WR. Synthesis of macrocyclic trypanosomal cysteine protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 5860-3. PMID 18585034 DOI: 10.1016/J.Bmcl.2008.06.012  0.506
2007 Goetz DH, Choe Y, Hansell E, Chen YT, McDowell M, Jonsson CB, Roush WR, McKerrow J, Craik CS. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus. Biochemistry. 46: 8744-52. PMID 17605471 DOI: 10.1021/Bi0621415  0.484
2004 Chen YT, Seto CT. Parallel synthesis of a library of bidentate protein tyrosine phosphatase inhibitors based on the alpha-ketoacid motif. Bioorganic & Medicinal Chemistry. 12: 3289-98. PMID 15158797 DOI: 10.1016/J.Bmc.2004.03.058  0.323
2002 Chen YT, Seto CT. Divalent and trivalent alpha-ketocarboxylic acids as inhibitors of protein tyrosine phosphatases. Journal of Medicinal Chemistry. 45: 3946-52. PMID 12190316 DOI: 10.1021/Jm020093Q  0.318
Show low-probability matches.